Design for the EMA [Regulatives / Guidelines]

posted by ryraman2661 – India, 2023-05-15 15:03 (786 d 18:25 ago) – Posting: # 23554
Views: 3,464

Dear Members,

I have one point to be discussed in the forum.

For Bioequivalence studies for EU submission, can we compare capsules VS tablets of same drug, and same strength.

If yes, whether both Cmax and AUC (total) to be included in the criteria? or we can compare only AUC (total).
What are the others points to be taken care.

Members can give their opinion.

Thanks

Raman
Chennai

Edit: Subject line changed; see also this post #2. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,684 registered users;
71 visitors (0 registered, 71 guests [including 25 identified bots]).
Forum time: 09:28 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5